News Archive

Events for the below selected month

Depiction of Oral Tumor-Induced Trigeminal Afferent Responses Using Single-Fiber Electrophysiology

Posted

15 March 2019

Considerable gap in knowledge exists about the mechanisms by which oral tumors regulate peripheral sensory fibers to produce pain and altered sensations. To address this gap, we used a murine model of oral squamous cell carcinoma (OSCC) of the...

BAHNO Research Grants

Posted

04 March 2019

Two awards given this year

BAHNO is pleased to announce that, due to the high standard of applications, the Research Committee has decided to make two awards this year. The recipients are: Paula Bradley (University of Sunderland) - who will receive £3,000 to develop...

Pool of Funding Released: Women’s Leadership Development

Posted

27 February 2019

Funding of up to £1,000 for surgery sector women available

Women & Leadership International is administering a national initiative to support the development of female leaders across the UK’s surgery sector. The campaign is providing women with grants of up to £1,000 to enable participation in a...

New cases of mouth cancer in the UK have now reached 8,302 a year

Posted

08 February 2019

The State of Mouth Cancer UK Report 2018/2019

This report is now available on the Oral Health Foundation website. A summary of the key findings: New cases of mouth cancer in the UK have now reached 8,302 a year. This has increased by 49% in the last decade and by 135% compared with...

Head and Neck Cancer UK

Posted

03 February 2019

HANCUK

The website for this charity is up and running: hancuk.org. This is a charity that is advocating for patients and their carers, raising awareness and providing information to patients and survivors of Head and Neck cancer in the UK.

LiTEFORM Trial

Posted

01 February 2019

News from Newcastle upon Tyne

LiTEFORM is a Randomised Controlled Trial of the Clinical and Cost Effectiveness of Low Level Laser in the Management of Oral Mucositis in Head and Neck Cancer Irradiation Please visit the LiTEFORM website to find out what LiTEFORM is, where it...

Vegetable intake and head and neck cancer survival are modestly associated

Posted

01 February 2019

Dietary behaviors and survival in people with head and neck cancer

This is an article from the NCBI in the United States Dietary behaviors and survival in people with head and neck cancer: Results from Head and Neck 5000. BACKGROUND: The association between diet and head and neck cancer (HNC)...

De-intensified treatment in human papillomavirus-positive oropharyngeal cancer

Posted

01 February 2019

Article in The Lancet

This article by Johannes Christiaan Oosthuizen and Jaime Doody may be viewed in full here.

Cancer patients in poor countries needlessly denied pain relief

Posted

01 February 2019

WHO report

Cancer patients in developing nations are being denied basic pain relief, often because of excessive fears about opioid abuse, the World Health Organisation (WHO) said on Thursday. Two-thirds of industrialized countries have oral morphine, an...

BAHNO International Collaboration Committee

Posted

28 January 2019

New Director and members announced by President

I am very pleased to announce that Dr Mehmet Sen, Consultant Oncologist, Leeds, will be taking over as Chair of the International Committee. Mehmet has long experience and expertise in the management of head and neck cancer, and has been...

Head & Neck TIG recruitment round

Posted

28 January 2019

Advert now live

The advert for the upcoming Head & Neck TIG recruitment round is now live on the Severn website.

Study suggests non-steroidal anti-inflammatory drugs such as aspirin may help some patients survive head and neck cancer

Posted

26 January 2019

Study in the Journal of Experimental Medicine

PIK3CA is the most commonly altered oncogene in head and neck squamous cell carcinoma (HNSCC). We evaluated the impact of nonsteroidal anti-inflammatory drugs (NSAIDs) on survival in a PIK3CA-characterized cohort of 266 HNSCC patients and explored...

Thousands of girls did not get full HPV vaccine

Posted

25 January 2019

TWO doses required

It has emerged that one in three girls in some parts of the UK did not have their full vaccination at school against HPV, the virus that can cause cervical cancer, in 2017-18. While the national target of immunising 80% of girls is being met, the...

HPV Action

Posted

25 January 2019

Suicide risk among cancer survivors

Posted

24 January 2019

Head & neck versus other cancers

The need for psychological support in patients with a history of head and neck cancer is highlighted in this study: https://onlinelibrary.wiley.com/doi/10.1002/cncr.31675

Smash your 2019 fitness goals in support of Saving Faces!

Posted

18 January 2019

Free charity places available in running events

Are you still looking for a challenge in 2019? Would you like to show support and raise money for our vital work? There's still time for you to register for a free charity place in some of the biggest and most iconic running events in London this...

Anaylsis of HPV teenage vaccination

Posted

18 January 2019

Human Papillomavirus Vaccination Before 13 and 15 Years of Age

An abstract has just been published of a study by Robert A Bednarczyk, Mallory K Ellingson and Saad B Omer of teenage HPV vaccination in the United States: Human papillomavirus (HPV) vaccination is suboptimally used in the United States....

Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable Human Papillomavirus 16-related cancer

Posted

17 January 2019

Encouraging results from a synthetic vaccine

Key points of this study: Question: Is the efficacy of programmed cell death 1 immune checkpoint inhibition increased by a tumor-specific vaccine in patients with incurable human papillomavirus 16-positive cancer? Findings: In the phase 2...

News from National Cancer Research Institute

Posted

17 January 2019

NCRI 2019 programme streams available

The NCRI 2019 Programme Streams and information about abstract submissions is now available on their website.

Final results of the larynx organ preservation trial DeLOX-II

Posted

17 January 2019

Important clinical trial information

Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II. The German...

Back to News Home